Lesson plan
JGB-1-155
JGB-1-155, is a drug which acts as a selective positive allosteric modulator of the enzyme nicotinamide phosphoribosyltransferase (NAMPT). It has neuroprotective effects, and was developed as a potential treatment for neurodegenerative diseases such as Alzheimer's disease.
Article summary
JGB-1-155, is a drug which acts as a selective positive allosteric modulator of the enzyme nicotinamide phosphoribosyltransferase (NAMPT). It has neuroprotective effects, and was developed as a potential treatment for neurodegenerative diseases such as Alzheimer's disease.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.